Literature DB >> 23133796

(18)F-FDG PET/CT: timing for evaluation of response to therapy remains a clinical challenge.

Andrei Iagaru1.   

Abstract

Utilizing novel imaging modalities for defining response and predicting long-term outcome after treatment may have a significant impact on cancer patient management. (18)F-FDG PET/CT has great potential for use in early assessment of response to cancer therapy. However, the lack of a general consensus on a specific set of response criteria makes adoption of PET difficult for the oncology community. The optimal time after initiating therapy for assessing response to treatment also has yet to be clearly determined.

Entities:  

Keywords:  18F-FDG; Cancer; PET/CT; Therapeutic response

Year:  2011        PMID： 23133796      PMCID： PMC3477715     

Source DB:  PubMed          Journal:  Am J Nucl Med Mol Imaging


  6 in total

Review 1.  A tabulated summary of the FDG PET literature.

Authors:  S S Gambhir; J Czernin; J Schwimmer; D H Silverman; R E Coleman; M E Phelps
Journal:  J Nucl Med       Date:  2001-05       Impact factor: 10.057

Review 2.  Molecular imaging in living subjects: seeing fundamental biological processes in a new light.

Authors:  Tarik F Massoud; Sanjiv S Gambhir
Journal:  Genes Dev       Date:  2003-03-01       Impact factor: 11.361

3.  New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada.

Authors:  P Therasse; S G Arbuck; E A Eisenhauer; J Wanders; R S Kaplan; L Rubinstein; J Verweij; M Van Glabbeke; A T van Oosterom; M C Christian; S G Gwyther
Journal:  J Natl Cancer Inst       Date:  2000-02-02       Impact factor: 13.506

Review 4.  Imaging in the era of molecular oncology.

Authors:  Ralph Weissleder; Mikael J Pittet
Journal:  Nature       Date:  2008-04-03       Impact factor: 49.962

5.  New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1).

Authors:  E A Eisenhauer; P Therasse; J Bogaerts; L H Schwartz; D Sargent; R Ford; J Dancey; S Arbuck; S Gwyther; M Mooney; L Rubinstein; L Shankar; L Dodd; R Kaplan; D Lacombe; J Verweij
Journal:  Eur J Cancer       Date:  2009-01       Impact factor: 9.162

6.  How to study optimal timing of PET/CT for monitoring of cancer treatment.

Authors:  Werner Vach; Poul Flemming Høilund-Carlsen; Barbara Malene Fischer; Oke Gerke; Wolfgang Weber
Journal:  Am J Nucl Med Mol Imaging       Date:  2011-07-20
  6 in total
  17 in total

Review 1.  Quantum dot-based nanoprobes for in vivo targeted imaging.

Authors:  Y Zhu; H Hong; Z P Xu; Z Li; W Cai
Journal:  Curr Mol Med       Date:  2013-12       Impact factor: 2.222

Review 2.  Multimodality imaging of CXCR4 in cancer: current status towards clinical translation.

Authors:  T R Nayak; H Hong; Y Zhang; W Cai
Journal:  Curr Mol Med       Date:  2013-12       Impact factor: 2.222

Review 3.  Biomedical applications of zinc oxide nanomaterials.

Authors:  Y Zhang; T R Nayak; H Hong; W Cai
Journal:  Curr Mol Med       Date:  2013-12       Impact factor: 2.222

Review 4.  Antibody-based imaging of HER-2: moving into the clinic.

Authors:  R E Wang; Y Zhang; L Tian; W Cai; J Cai
Journal:  Curr Mol Med       Date:  2013-12       Impact factor: 2.222

5.  In a "nutshell": intrinsically radio-labeled quantum dots.

Authors:  Weibo Cai; Hao Hong
Journal:  Am J Nucl Med Mol Imaging       Date:  2012-03-28

6.  In vivo targeting and positron emission tomography imaging of tumor vasculature with (66)Ga-labeled nano-graphene.

Authors:  Hao Hong; Yin Zhang; Jonathan W Engle; Tapas R Nayak; Charles P Theuer; Robert J Nickles; Todd E Barnhart; Weibo Cai
Journal:  Biomaterials       Date:  2012-03-03       Impact factor: 12.479

7.  ImmunoPET and near-infrared fluorescence imaging of CD105 expression using a monoclonal antibody dual-labeled with (89)Zr and IRDye 800CW.

Authors:  Yin Zhang; Hao Hong; Gregory W Severin; Jonathan W Engle; Yunan Yang; Shreya Goel; Alex J Nathanson; Glenn Liu; Robert J Nickles; Bryan R Leigh; Todd E Barnhart; Weibo Cai
Journal:  Am J Transl Res       Date:  2012-07-27       Impact factor: 4.060

8.  Imaging tumor angiogenesis in breast cancer experimental lung metastasis with positron emission tomography, near-infrared fluorescence, and bioluminescence.

Authors:  Yin Zhang; Hao Hong; Tapas R Nayak; Hector F Valdovinos; Duane V Myklejord; Charles P Theuer; Todd E Barnhart; Weibo Cai
Journal:  Angiogenesis       Date:  2013-03-08       Impact factor: 9.596

9.  Tumor vasculature targeting and imaging in living mice with reduced graphene oxide.

Authors:  Sixiang Shi; Kai Yang; Hao Hong; Hector F Valdovinos; Tapas R Nayak; Yin Zhang; Charles P Theuer; Todd E Barnhart; Zhuang Liu; Weibo Cai
Journal:  Biomaterials       Date:  2013-01-29       Impact factor: 12.479

Review 10.  Synthesis and biomedical applications of copper sulfide nanoparticles: from sensors to theranostics.

Authors:  Shreya Goel; Feng Chen; Weibo Cai
Journal:  Small       Date:  2013-09-19       Impact factor: 13.281
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.